Navigation Links
Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Date:1/14/2008

America and Europe.

The company's second Phase 3 trial, VITAL-2, is a multi-center, randomized, controlled Phase 3 clinical trial designed to evaluate the safety and efficacy of GVAX immunotherapy for prostate cancer used in combination with Taxotere chemotherapy compared to the use of Taxotere chemotherapy and prednisone in HRPC patients with metastatic disease who are symptomatic with cancer-related pain. The primary endpoint of the trial is also an improvement in survival. VITAL-2 was initiated in June 2005 and is currently enrolling patients at approximately 90 sites in North America and Europe. The company expects to complete enrollment of approximately 600 patients in the first half of 2009 and if this is achieved, to have a sufficient number of events for a pre-planned interim analysis at that time.

The U.S. Food and Drug Administration (FDA) granted Cell Genesys Special Protocol Assessments (SPAs) for both VITAL-1 and VITAL-2. The SPA is a process that allows for official FDA evaluation of a Phase 3 clinical trial and provides trial sponsors with a binding written agreement that the design and analysis of the study are adequate to support a license application submission if that study is performed according to the SPA. Cell Genesys completed the modifications requested by FDA during the review process.

About GVAX Cancer Immunotherapies

GVAX cancer immunotherapies are non patient-specific investigational therapeutics comprised of whole tumor cells that have been modified to secrete GM-CSF (granulocyte-macrophage colony stimulating factor), an immune stimulatory hormone, and then irradiated for safety. GVAX is designed to be administered through intradermal injections on an outpatient basis. To date, over 600 patients have been treated with GVAX cancer immunotherapies in Phase 1 and Phase 2 clinical trials for multiple indications, including prostate cancer, pancreatic cancer, and leukemia. The company is currently manufacturing GV
'/>"/>

SOURCE Cell Genesys, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
5. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
8. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
9. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
10. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
11. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 For the pharmaceutical industry, marketplace success is ... Likewise, the importance of the managed markets function - which ... grow as payer formularies and provider networks play an increasingly ... the same time, managed markets leaders must continually identify the ...
(Date:1/23/2015)... Jan. 23, 2015 Research and Markets ( ... "Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters ... Analysis, Size, Share, Growth, Trends and Forecast 2014 - ... At present, the global market for urinary catheters ...
(Date:1/23/2015)... Jan. 23, 2015  MedScope ( www.medscope.org ), the leading ... a 2015 Connected World magazine Connected World ... (mPERS), that can be used anywhere, anytime. The nomination ... In nominating MedScope, Landon Garner , ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2
... , , , ... Ltd., an emerging life science company specializing in forensic DNA analysis, ... scenes can easily be falsified using basic equipment, know-how and access ... safeguard the accuracy and credibility of DNA samples in the field ...
... , , , , ... Aug. 17 The US Food and Drug Administration (FDA) has approved ... sclerosis (MS) medicines from Novartis to help patients manage this devastating disease. ... for the treatment of relapsing forms of MS to reduce the frequency ...
Cached Medicine Technology:Nucleix Researchers Discover DNA Evidence May Easily Be Falsified 2Nucleix Researchers Discover DNA Evidence May Easily Be Falsified 3Nucleix Researchers Discover DNA Evidence May Easily Be Falsified 4US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 2US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 3US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 5US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 6US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 7
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering ... follow it on Facebook, Twitter, and Pinterest. The fans will ... draws a lottery every week. , Moreover, the company has ... Click Angelweddingdress homepage for more information. , ...
(Date:1/22/2015)... 22, 2015 Juvent Sports ( http://www.juventsports.com ... 2015 PGA Merchandise Show to bestow a Juvent Sports ... amateur golfer, Arlene McKitrick. The award commemorated and congratulated ... tournament win. She won her first amateur tournament in ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that can ... for those same twenty-plus years, the team at Doctors on ... the best possible doctor. With the combined breadth of ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... CINCINNATI, July 23 LCA-Vision Inc. (Nasdaq: LCAV ... the Lasik Plus ((R)) brand, today announced that members of ... Annual Small-Cap Investor Conference on Wednesday, July 29, 2009 at ... conference is being held at Hyatt Regency Hotel in Milwaukee, ...
... SHENYANG, China, July 23 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: ... focused on,researching, developing, manufacturing and marketing biopharmaceutical,products, today announced ... ended June 30, 2009 after the US market closes ... Following the earnings announcement, 3SBio,s senior management will host ...
... ... holistic health career opportunities available in the wellness industry today. , ... Seattle, Washington (Vocus) July 23, 2009 ... of years, but these ancient and effective methods of healing have recently reached a ...
... diet high in omega-3 fatty acids may help prevent one of ... report by Tuo et al, "A high omega-3 fatty acid diet ... in the August 2009 issue of the American Journal of ... the center of the visual field (macula) due to retinal damage, ...
... The European Working ... a 48-hour week. Aimed at protecting trainee doctors, health and safety from the effects of ... writes Robert Stiff MD Team24. , ... (PRWeb UK) July 22, 2009 -- The image of the dishevelled, tired and ...
... testing shows devices contain carcinogens, other toxins , ... electronic cigarettes, known as e-cigarettes, has shown that ... a compound used in antifreeze, U.S. health officials ... contain cartridges filled with nicotine, flavorings and other ...
Cached Medicine News:Health News:3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009 2Health News:3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009 3Health News:Natural Healers Discusses How Alternative Medicine Careers Provide a Little 'Wellness' in a Tough Economy 2Health News:Natural Healers Discusses How Alternative Medicine Careers Provide a Little 'Wellness' in a Tough Economy 3Health News:The 'see food' diet 2Health News:Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 2Health News:Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 3Health News:E-Cigarettes Pose a Health Hazard, FDA Warns 2Health News:E-Cigarettes Pose a Health Hazard, FDA Warns 3
EchoScan US-3300 takes accurate axial length and corneal thickness measurements in either automatic or manual modes. It is available in a single configuration or in combination with the A scan for ma...
... the total eye. Whether used as ... or set independently to accommodate a ... are adjustable to accommodate maximizing the ... use with tonometer-mounted, hand-held and immersion ...
PremierEdge™ Stab Knives - 15°....
... Micro-Incision Cataract Surgery (MICS) Is ... unique double-step hexagonal shape, the ... for MICS. The consistently sharp-edged ... allow you to obtain accurate ...
Medicine Products: